| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039715988 |
| P356 | DOI | 10.1038/349342A0 |
| P953 | full work available at URL | http://www.nature.com/articles/349342a0 |
| http://www.nature.com/articles/349342a0.pdf | ||
| P698 | PubMed publication ID | 1846231 |
| P2093 | author name string | Ito K | |
| Watanabe T | |||
| Nakamura M | |||
| Honda Z | |||
| Seyama Y | |||
| Minami M | |||
| Miyamoto T | |||
| Toh H | |||
| Miki I | |||
| Okado H | |||
| P2860 | cites work | American Journal of Physiology | Q2160146 |
| Cloning and expression of a rat D2 dopamine receptor cDNA | Q28567326 | ||
| Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family | Q28569921 | ||
| Molecular cloning of the thyrotropin receptor | Q34457109 | ||
| Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin | Q34684390 | ||
| cDNA cloning of bovine substance-K receptor through oocyte expression system. | Q36288721 | ||
| Arachidonic acid cascade and signal transduction | Q37815882 | ||
| Platelet activating factor: a biologically active phosphoglyceride | Q39503946 | ||
| Characterization of platelet-activating factor-induced elevation of cytosolic free calcium concentration in eosinophils | Q42505317 | ||
| [3H]WEB 2086 labels platelet activating factor receptors in guinea pig and human lung | Q44147156 | ||
| Human cytomegalovirus encodes three G protein-coupled receptor homologues | Q48269680 | ||
| Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin | Q48396113 | ||
| Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists. | Q53900185 | ||
| Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor | Q68401166 | ||
| A family of receptors coupled to guanine nucleotide regulatory proteins | Q70185993 | ||
| P433 | issue | 6307 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pig | Q787 |
| gene expression | Q26972 | ||
| platelet membrane glycoproteins | Q7202248 | ||
| G protein-coupled receptor | Q38173 | ||
| molecular cloning | Q408351 | ||
| P304 | page(s) | 342-346 | |
| P577 | publication date | 1991-01-01 | |
| 1991-01-24 | |||
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung | |
| P478 | volume | 349 |
| Q24308699 | A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis |
| Q72741855 | A Monte Carlo pharmacophore generation procedure: application to the human PAF receptor |
| Q41988173 | A murine platelet-activating factor receptor gene: cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages |
| Q28138986 | A novel subgroup of class I G-protein-coupled receptors |
| Q73388666 | A pharmacophore for high affinity PAF antagonists. II. Hydrophobicity study using the molecular lipophilicity potential |
| Q43976649 | A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis |
| Q42276763 | A radioreceptor binding assay for platelet-activating factor (PAF) using membranes from CHO cells expressing human PAF receptor |
| Q40572463 | Activation of mitogen-activated protein kinase and arachidonate release via two G protein-coupled receptors expressed in the rat hippocampus |
| Q44227243 | Activation of vascular cells by PAF-like lipids in oxidized LDL. |
| Q52539845 | Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. |
| Q41453295 | Agonist-induced down-regulation of platelet-activating factor receptor gene expression in U937 cells |
| Q46894522 | Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor receptor. Role of cytoplasmic tail phosphorylation in each process |
| Q43854264 | Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway |
| Q46793657 | Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants |
| Q34087866 | Amino acid residues critical for endoplasmic reticulum export and trafficking of platelet-activating factor receptor |
| Q36693457 | Amino-acid sequence and tissue distribution of guinea-pig leukotriene A4 hydrolase |
| Q49092606 | Attenuated LTP in hippocampal dentate gyrus neurons of mice deficient in the PAF receptor |
| Q42059370 | Boosting Adaptive Immunity: A New Role for PAFR Antagonists. |
| Q33885948 | Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. |
| Q74522452 | Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors |
| Q24311426 | Characterization of a human cDNA that encodes a functional receptor for platelet activating factor |
| Q42107170 | Characterization of platelet-activating factor binding to human airway epithelial cells: modulation by fatty acids and ion-channel blockers |
| Q42797984 | Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells |
| Q35848282 | Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes |
| Q30440405 | Chemical and biochemical characterization of lignan analogs as novel PAF receptor antagonists |
| Q48068204 | Cloning and expression of a cDNA encoding the beta-subunit (30-kDa subunit) of bovine brain platelet-activating factor acetylhydrolase |
| Q28263042 | Cloning of a human platelet-activating factor receptor gene: evidence for an intron in the 5'-untranslated region |
| Q24311854 | Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA |
| Q24304193 | Cloning, sequencing and tissue distribution of two related G protein-coupled receptor candidates expressed prominently in human lung tissue |
| Q39208689 | Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation. |
| Q36532906 | Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils |
| Q43934789 | Comparison of the coding sequence of the platelet-activating factor receptor gene in three species |
| Q44991325 | Components of a platelet-activating factor-signaling loop are assembled in the ovine endometrium late in the estrous cycle |
| Q73712821 | Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population |
| Q34756757 | Critical duration of intracellular Ca2+ response required for continuous translocation and activation of cytosolic phospholipase A2. |
| Q36626924 | Cytokine gene regulation by PGE(2), LTB(4) and PAF |
| Q53859829 | Demonstration of platelet activating factor receptor in guinea pig kidney |
| Q24294397 | Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma |
| Q35605613 | Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae. |
| Q48290616 | Down-regulation of platelet-activating factor receptor gene expression during focal reversible cerebral ischemia in rats |
| Q36403038 | Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor |
| Q42502249 | Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells |
| Q53736678 | Effect of platelet-activating factor receptor expression on CHO cell motility. |
| Q58299986 | Effects of Platelet-Activating Factor (PAF) Receptor Blockage on Mucous Glycoprotein Secretion in Cultured Chinchilla Middle Ear Epithelium |
| Q52689356 | Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells. |
| Q40698890 | Effects of platelet-activating factor on human T and B cells--an overview |
| Q41087045 | Endotoxin transduces Ca2+ signaling via platelet-activating factor receptor |
| Q28609570 | Enzymes of platelet activating factor synthesis in brain |
| Q40973823 | Eosinophils: biology and role in disease |
| Q34161044 | Events at the vascular wall: the molecular basis of inflammation |
| Q73889725 | Evidence for platelet-activating factor receptor subtypes on human polymorphonuclear leukocyte membranes |
| Q73877696 | Evidence for the autocrine induction of capacitation of mammalian spermatozoa |
| Q36882223 | Evolution of Enzymatic regulation of prostaglandin action: Novel connections to regulation of human sex and adrenal function, antibiotic synthesis and nitrogen fixation |
| Q43955139 | Excitatory and neurotoxic actions of platelet-activating factor on rat myenteric neurons in cell culture |
| Q36337940 | Expression cloning of an ATP receptor from mouse neuroblastoma cells |
| Q31996605 | Expression cloning using Xenopus laevis oocytes |
| Q24528229 | Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation |
| Q58853832 | Functional Microdomains in G-protein-coupled Receptors |
| Q43230859 | Functional analysis of platelet-activating factor in the retinal pigment epithelial cells and choroidal endothelial cells |
| Q49027821 | G alpha-16 complements the signal transduction cascade of chemotactic receptors for complement factor C5a (C5a-R) and N-formylated peptides (fMLF-R) in Xenopus laevis oocytes: G alpha-16 couples to chemotactic receptors in Xenopus oocytes |
| Q41997956 | Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase |
| Q49061386 | Gq pathway desensitizes chemotactic receptor-induced calcium signaling via inositol trisphosphate receptor down-regulation |
| Q42807951 | Gq-coupled receptors transmit the signal for GLUT4 translocation via an insulin-independent pathway |
| Q34229649 | Group A Streptococcus secreted esterase hydrolyzes platelet-activating factor to impede neutrophil recruitment and facilitate innate immune evasion |
| Q41766401 | Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids |
| Q41413573 | Guanosine 5'-[gamma-thio]triphosphate induces membrane localization of cytosol-independent phospholipase D activity in a cell-free system from U937 promonocytic leucocytes |
| Q77799759 | Heterogeneous platelet-activating factor (PAF) receptors and calcium increase in platelets and macrophages |
| Q41652141 | Human PAF receptor gene expression: Induction during HL-60 cell differentiation |
| Q71840119 | Human umbilical vein endothelial cells: Specific binding of platelet-activating factor and cytosolic calcium flux |
| Q36377463 | Identification and functional characterization of platelet-activating factor receptors in human leukocyte populations using polyclonal anti-peptide antibody |
| Q40973067 | Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases |
| Q24336561 | Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor |
| Q33938008 | Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid |
| Q34457192 | Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men. |
| Q28295613 | Identification of the Major Phosphorylation Sites in Human C5a Anaphylatoxin Receptor in Vivo |
| Q42554177 | Identification of transmembrane domain residues determinant in the structure-function relationship of the human platelet-activating factor receptor by site-directed mutagenesis. |
| Q41654193 | Immunoregulatory functions of paf-acether. VI. Dual effect on human B cell proliferation. |
| Q36400935 | Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor |
| Q46909446 | Increasing Intracellular calcium of guinea pig ventricular myocytes induced by platelet activating factor through IP3 pathway |
| Q44379259 | Induction of high-affinity paf receptor expression during T cell activation |
| Q47882875 | Inhibition of Na+,K(+)-ATPase by platelet-activating factor in dog submandibular glands |
| Q71946986 | Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotamides |
| Q42717473 | Inhibition of human neutrophil responses by alpha-cyano-3,4-dihydroxythiocinnamamide; a protein-tyrosine kinase inhibitor |
| Q43406274 | Intracamerally injected platelet activating factor (PAF) induces marked intraocular inflammatory reactions |
| Q58831793 | Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-α or interleukin-1α |
| Q48229426 | Involvement of platelet-activating factor and LIS1 in neuronal migration |
| Q42161482 | Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A-431 cells. |
| Q28274008 | Isolation and characterisation of the human lung NK-2 receptor gene using rapid amplification of cDNA ends |
| Q48185395 | LIS1 and platelet-activating factor acetylhydrolase (Ib) catalytic subunits, expression in the mouse oocyte and zygote |
| Q35238508 | Leukotriene B4 and platelet-activating factor in human skin |
| Q48949285 | Lipid mediators modulate NMDA receptor currents in a Xenopus oocyte expression system. |
| Q36217327 | Lipid signaling in neural plasticity, brain repair, and neuroprotection |
| Q35985649 | Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance |
| Q35787004 | Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells |
| Q41662880 | Long time incubation of monocytic U 937 cells with LDL increases specific paf-acether binding and the cellular acetylhydrolase activity |
| Q34793591 | Long-lasting inhibitory activity of the hetrazepinic BN 50730 on exudation and cellular alterations evoked by PAF and LPS. |
| Q42821442 | Lysophospholipids activate ovarian and breast cancer cells |
| Q36435393 | Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers |
| Q60666892 | Mannan and peptidoglycan induce COX-2 protein in human PMNvia the mammalian target of rapamycin |
| Q28269315 | Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19 |
| Q28366084 | Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants |
| Q73146733 | Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils |
| Q24313605 | Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase [corrected] |
| Q35210290 | Molecular Architecture of G Protein-Coupled Receptors. |
| Q28368966 | Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils |
| Q41307210 | Molecular and cellular mechanisms of pneumococcal meningitis |
| Q46581271 | Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation |
| Q44403160 | Molecular biology. Inflammatory activities |
| Q24306153 | Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart |
| Q37036850 | Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. |
| Q38660494 | Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer |
| Q24629279 | Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor |
| Q48972578 | Mutant of insulin receptor substrate-1 incapable of activating phosphatidylinositol 3-kinase did not mediate insulin-stimulated maturation of Xenopus laevis oocytes |
| Q48179258 | Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue |
| Q74034567 | Neuronal platelet-activating factor receptor signal transduction involves a pertussis toxin-sensitive G-protein |
| Q36531315 | Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8 |
| Q70201773 | New nucleotide sequence data on the EMBL File Server |
| Q42563701 | Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation |
| Q40370871 | Overexpression of integral membrane proteins for structural studies |
| Q35766281 | Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells |
| Q43705162 | Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity |
| Q28348220 | Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages |
| Q41121327 | PAF and asthma--time for an appraisal? |
| Q35829542 | PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis |
| Q42920804 | Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart |
| Q47688088 | Phagocyte chemoattractant receptors |
| Q77676188 | Pharmacological analysis of protein kinases responsible for chemotaxis of rat peritoneal neutrophils |
| Q33500352 | Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambin. |
| Q42549572 | Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist |
| Q42081943 | Phospholipase A2 from bovine seminal plasma is a platelet-activating factor acetylhydrolase. |
| Q40524595 | Platelet activating factor antagonists |
| Q48181308 | Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. |
| Q35752847 | Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis |
| Q39411033 | Platelet activating factor-induced increase in cytosolic calcium and transmembrane current in human macrophages |
| Q38993442 | Platelet activating factor: A potential biomarker in acute coronary syndrome? |
| Q41091749 | Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor |
| Q28609411 | Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice |
| Q36870588 | Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery |
| Q74788274 | Platelet-activating factor acetylhydrolase in seminal plasma: a brief review |
| Q35418559 | Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene |
| Q41335954 | Platelet-activating factor in the CNS. |
| Q40442514 | Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase |
| Q36546304 | Platelet-activating factor induces collagenase expression in corneal epithelial cells |
| Q44059814 | Platelet-activating factor induces permeability transition and cytochrome c release in isolated brain mitochondria |
| Q24323331 | Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells |
| Q41298937 | Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice |
| Q40400398 | Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties |
| Q28214944 | Platelet-activating factor receptor |
| Q39100666 | Platelet-activating factor receptor blockade ameliorates Aggregatibacter actinomycetemcomitans-induced periodontal disease in mice |
| Q48248257 | Platelet-activating factor receptor is not required for long-term potentiation in the hippocampal CA1 region |
| Q48558784 | Platelet-activating factor receptor stimulation disrupts neuronal migration In vitro. |
| Q44804975 | Platelet-activating factor receptor-deficient mice are protected from experimental sleep apnea-induced learning deficits |
| Q38296767 | Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes. Correlation with an increased kappa B binding activity |
| Q30959719 | Platelet-activating factor-induced intracellular calcium waves in human uterine myometrial cells |
| Q35821302 | Platelet-activating factor-mediated transmembrane signaling in human B lymphocytes is regulated through a pertussis- and cholera toxin-sensitive pathway |
| Q36623039 | Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin |
| Q28609556 | Platelet-activating factor: receptors and signal transduction |
| Q40430459 | Platelets and Platelet Inhibitors in Acute Myocardial Infarction |
| Q35754470 | Potential angiogenic role of platelet-activating factor in human breast cancer |
| Q64975474 | Predominant expression of platelet-activating factor receptor in the rat brain microglia. |
| Q33298062 | Production of platelet-activating factor in photocoagulated retinas |
| Q41828151 | Prolonged activation of phospholipase D in Chinese hamster ovary cells expressing platelet-activating-factor receptor lacking cytoplasmic C-terminal tail |
| Q41128402 | Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells |
| Q41847902 | Protein tyrosine phosphorylation and regulation of the receptor for platelet-activating factor in rat Kupffer cells. Effect of sodium vanadate |
| Q92033815 | PsychoNeuroImmunology Goes East: Development of the PNIRSChina Affiliate and Its Expansion into PNIRSAsia-Pacific |
| Q37653155 | Receptor class desensitization of leukocyte chemoattractant receptors |
| Q38293081 | Receptor-dependent metabolism of platelet-activating factor in murine macrophages |
| Q45856333 | Reduction in the extent of atherosclerosis in apolipoprotein E-deficient mice induced by electroporation-mediated transfer of the human plasma platelet-activating factor acetylhydrolase gene into skeletal muscle |
| Q41161821 | Regulation of platelet-activating factor receptor expression in human B cells and B cell lines. |
| Q28379513 | Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor |
| Q40572457 | Regulation of prostaglandin E2 production in P388D1 macrophage-like cells |
| Q42794891 | Regulation of the receptor for platelet-activating factor on human platelets |
| Q33933810 | Reperfusion injury after focal myocardial ischaemia: polymorphonuclear leukocyte activation and its clinical implications |
| Q33858841 | Role of G protein-coupled receptors in inflammation. |
| Q41111050 | Role of phospholipase Cbeta3 phosphorylation in the desensitization of cellular responses to platelet-activating factor |
| Q40731805 | Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes |
| Q28574482 | Roles of C-terminal Src kinase in the initiation and the termination of the high affinity IgE receptor-mediated signaling |
| Q30175249 | Sequential requirements of the N-terminal palmitoylation site and SH2 domain of Src family kinases in the initiation and progression of FcepsilonRI signaling |
| Q28566629 | Similar coronary vascular effects in the rat perfused heart of platelet-activating factor structural analogues with agonist and antagonist properties |
| Q41869431 | Solubilization of a functionally active platelet-activating factor receptor from rabbit platelets |
| Q46481816 | Species differences in PAF receptor binding in the lungs between hamster and guinea pig. |
| Q43435042 | Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor |
| Q42159046 | Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells |
| Q28289854 | Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor |
| Q40521616 | Structural and (patho)physiological diversity of PAF. |
| Q28541704 | Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi |
| Q35730371 | Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils |
| Q41478095 | Structure and function of leukocyte chemoattractant receptors |
| Q59394723 | Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties |
| Q34396429 | Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist |
| Q67886521 | Synthesis and proaggregatory activity of 1-O-(2-methyloctadecyl)-2-O-acetyl-rac-glycero-3-phosphocholine |
| Q90341485 | Systematic Understanding of Bioactive Lipids in Neuro-Immune Interactions: Lessons from an Animal Model of Multiple Sclerosis |
| Q58831684 | Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat |
| Q37381694 | The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow |
| Q40855367 | The GTPase Rap1 controls functional activation of macrophage integrin alphaMbeta2 by LPS and other inflammatory mediators |
| Q38007464 | The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids |
| Q50262544 | The ether lipid trail: a historical perspective |
| Q24336964 | The human platelet-activating factor receptor gene (PTAFR) contains no introns and maps to chromosome 1 |
| Q28362314 | The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase |
| Q77908741 | The pig platelet-activating factor receptor gene is expressed at the mRNA level in different tissues and is mapped to chromosome 6 |
| Q67487680 | The presence of platelet-activating factor binding sites in human myometrium and their role in uterine contraction |
| Q42710783 | The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis |
| Q34808609 | The role of platelet-activating factor in the corneal response to injury |
| Q28574392 | The third intracellular domain of the platelet-activating factor receptor is a critical determinant in receptor coupling to phosphoinositide phospholipase C-activating G proteins. Studies using intracellular domain minigenes and receptor chimeras |
| Q33578411 | Tissue-specific response of the human platelet-activating factor receptor gene to retinoic acid and thyroid hormone by alternative promoter usage |
| Q72074570 | Tumor necrosis factor induces enhanced responses to platelet‐activating factor and differentiation in human monocytic Mono Mac 6 cells |
| Q28263300 | Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor |
| Q40828866 | Tyrosine kinases in platelet signalling |
| Q28076917 | Unique aspects of the developing lung circulation: structural development and regulation of vasomotor tone |
| Q35800185 | Up-regulation of platelet-activating factor synthases and its receptor in spinal cord contribute to development of neuropathic pain following peripheral nerve injury |
| Q37157003 | Using guinea pigs in studies relevant to asthma and COPD. |
| Q30749366 | cDNA cloning and characterization of guinea-pig leukotriene B4 receptor |
Search more.